Cargando…
Actovegin® reduces PMA-induced inflammation on human cells
PURPOSE: The effect of Actovegin® was investigated on PMA- and LPS-induced human peripheral blood mononuclear cells (PBMCs). METHODS: PBMCs (1 × 10(6) cells/ml) from five blood donors (2 f, 3 m; 45–55 years) were grown in medium and exposed to Actovegin® in the presence or absence of PMA or LPS. Sup...
Autores principales: | Reichl, Franz-Xaver, Högg, Christof, Liu, Fangfang, Schwarz, Markus, Teupser, Daniel, Hickel, Reinhard, Bloch, Wilhelm, Schweikl, Helmut, Thomas, Peter, Summer, Burkhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497287/ https://www.ncbi.nlm.nih.gov/pubmed/32447451 http://dx.doi.org/10.1007/s00421-020-04398-2 |
Ejemplares similares
-
Correction to: Actovegin® reduces PMA‑induced inflammation on human cells
por: Reichl, Franz-Xaver, et al.
Publicado: (2021) -
Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients
por: Ziegler, Dan, et al.
Publicado: (2009) -
Actovegin in the management of patients after ischemic stroke: A systematic review
por: la Fleur, Philip, et al.
Publicado: (2022) -
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment
por: Guekht, Alla, et al.
Publicado: (2017) -
Neuroprotective and Anti-Oxidative Effects of the Hemodialysate Actovegin on Primary Rat Neurons in Vitro
por: Elmlinger, Martin W., et al.
Publicado: (2011)